Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus

scientific article

Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.1780170205
P698PubMed publication ID4131150

P2093author name stringEpstein WV
Grausz H
P2860cites workCyclophosphamide in lupus nephritis: a controlled trialQ34201904
The clinical course of the proliferative and membranous forms of lupus nephritis.Q47728168
P433issue2
P921main subjectproliferative glomerulonephritisQ18556474
systemic lupus erythematosusQ1485
glomerulonephritisQ605006
P304page(s)129-142
P577publication date1974-03-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleFavorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus
P478volume17

Reverse relations

cites work (P2860)
Q69225849Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin
Q40497391Clinical use of immunosuppressive drugs: part I
Q39536979Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis
Q44009488Glomerulonephritis — 1974
Q33452842Immunologic findings, thrombocytopenia and disease activity in lupus nephritis
Q36269226Immunosuppressive Therapy in Rheumatic Disease
Q40665188Lupus nephritis in childhood and adolescence
Q68125366Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)
Q42823544Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study
Q67337023On survivorship in the nephritis of systemic lupus erythematosus
Q80689056Outcome of lupus nephritis in Iranian children: prognostic significance of certain features
Q52103115Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosis
Q34302895Problems with immunosuppressive agents in renal disease
Q41331115Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis
Q33824546Recent advances in the immunopathogenesis of systemic lupus erythematosus
Q33987313Recent observations on central nervous system lupus erythematosus
Q67564579The clinical aspects of systemic lupus erythematosus
Q38791636The treatment of lupus nephritis
Q67592070The treatment of the nephritis of lupus erythematosus
Q64389051Urinary loss of immunoglobulin G anti-F(ab)2 and anti-DNA antibody in systemic lupus erythematosus nephritis

Search more.